Financial assets:
Trade receivables(i)
Available-for-sale securities(ii)
Fair value of derivative financial instruments(iii)
Financial liabilities:
Fair value of derivative financial instruments(iii)
The following table sets out the Company's financial assets and liabilities measured at fair value as at December 31, 2013 using the fair value hierarchy:
| Level 1 | Level 2 | Level 3 | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial assets: | ||||||||||||||
Trade receivables(i) | $ | — | $ | 67,300 | $ | — | $ | 67,300 | ||||||
Available-for-sale securities(ii) | 74,581 | — | — | 74,581 | ||||||||||
Fair value of derivative financial instruments(iii) | — | 5,590 | — | 5,590 | ||||||||||
| $ | 74,581 | $ | 72,890 | $ | — | $ | 147,471 | ||||||
Financial liabilities: | ||||||||||||||
Fair value of derivative financial instruments(iii) | $ | — | $ | 467 | $ | — | $ | 467 | ||||||
Notes:
In the event that a decline in the fair value of an investment in available-for-sale securities occurs and the decline in value is considered to be other-than-temporary, an impairment charge is recorded in the interim unaudited consolidated statements of income and comprehensive income and a new cost basis for the investment is established. The Company assesses whether a decline in value is considered to be other-than-temporary by considering available evidence, including changes in general market conditions, specific industry and investee data, the length of time and the extent to which the fair value has been less than cost, the financial condition of the investee and the near-term prospects of the individual investment. New evidence could become available in future periods which would affect this assessment and thus could result in material impairment charges with respect to those investments in available-for-sale securities for which the cost basis exceeds its fair value.